Company Overview and News

MetLife's Approves Share Buyback, Boosts Shareholders' Value

2018-05-23 zacks
MetLife, Inc.’s (MET - Free Report) board of directors has approved a new buyback authorization of common shares worth $1.5 billion. The recent announcement is in tandem with the company’s goal of returning $5 billion in capital to its shareholders in 2018. Last year, the company had announced a $2 billion repurchase under which it has bought back nearly $1.63 billion worth shares. Shares worth around $370 million still remains under its 2017 authorization.

House passes bill to roll back regulations on small and midsize banks

2018-05-22 feeds.marketwatch
Congress took a big step Tuesday to relax a wave of crisis-era restrictions placed on financial firms, as the House approved a plan to ease rules for small and midsize banks. Full Story

MET / MetLife, Inc. 8-K (Current Report)


MetLife Moving Past Some Self-Inflicted Challenges And Toward Unlocking Value

2018-05-22 seekingalpha
MetLife has hurt its own cause with inconsistent results, while also seeing market pressures in several business and ROE drag from its run-off operations.

Social media giant Facebook leases entire tower in San Francisco expansion

2018-05-22 bworldonline
FACEBOOK, INC. is constantly expanding in its Silicon Valley hometown of Menlo Park, California. Now it’s making a bigger push into San Francisco.

MetLife: Profitability Is Set To Improve

2018-05-21 seekingalpha
Since the beginning of the year, MetLife has been hit hard by a string of charges related to the company’s review of its practices and procedures.

SA Interview: Special Situation Investing With Antao

2018-05-20 seekingalpha
The two most important factors when evaluating a special situation idea, why there are still opportunities in spin-offs and why your thesis should fit on one page are topics discussed. highlights: Western Digital, Discovery, AerCap Holdings and MetLife

2018-05-18 zacks
Chicago, IL – May 18, 2018 - Stocks in this week’s article include: Western Digital Corp. (WDC - Free Report) , Discovery, Inc. (DISCA - Free Report) , AerCap Holdings N.V. (AER - Free Report) and MetLife, Inc. (MET - Free Report) .

MET / MetLife, Inc. 8-K (Current Report)


Progressive's April Earnings Grow on Robust Revenue Rise

2018-05-17 zacks
The Progressive Corporation (PGR - Free Report) reported earnings per share of 45 cents for April 2018, surging 36% year over year. Moreover, the bottom line is driven by an improved top line. Quarter to date, Progressive’s shares have gained 1.1%, outperforming the industry’s 1.2% decrease. This share price rise was courtesy of the company’s sustained strong results.

Kemper (KMPR) Hits 52-Week High: Will the Stock Rally Ahead?

2018-05-17 zacks
Shares of Kemper Corporation (KMPR - Free Report) hit a new 52-week high of $75 on May 16, gaining traction from a strong first-quarter 2018 earnings release. About 0.4 million shares exchanged hands in the last trading session and the stock finally closed at $74.75, inching up 1.7%. The company’s return on equity has been an impressive 9.1% when compared with the industry average of 4.8%. Solid Q1 Results Kemper’s bottom line of $1.

Add Value to Your Investment With These 4 Low P/CF Stocks

2018-05-17 zacks
Investors always try to hit the jackpot while picking stocks. But striking the right chord each time is not easy unless you are blessed with Midas touch.

MET / MetLife, Inc. 8-K/A (Current Report)


MET / MetLife, Inc. 8-K (Current Report)


MetLife: Why I Am Staying The Course With This 'Troubled' Insurer

2018-05-15 seekingalpha
MetLife reported strong Q1 2018 operating results and its management team recently increased the quarterly dividend by 5%.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 59156R108